Abstract
Two variants of recombinant human bone morphogenetic protein-2 (rhBMP-2) with additional N-terminal protein domains were obtained by expression in E. coli. The N-terminal domains were s-tag (15-a.a. oligopeptide from bovine pancreatic ribonuclease A) and lz (leucine zipper dimerization domain from yeast transcription factor GCN4). The s-tag-BMP-2 and lz-BMP-2 were purified by a procedure that excluded a long refolding stage. The resulting dimeric proteins displayed higher solubility compared to rhBMP-2 without additional protein domains. Biological activity of both proteins was demonstrated in vitro by induction of alkaline phosphatase in C2C12 cells, and the activity of s-tag-BMP-2 in vivo was shown in various experimental animal models.
Similar content being viewed by others
Abbreviations
- a.a.:
-
amino acid residue
- BCA:
-
2,2′-bicinchoninic acid
- BMP-2:
-
bone morphogenetic protein-2
- hBMP-2:
-
human BMP-2
- lz:
-
fragment of yeast GCN4 transcription factor corresponding to GCN4 leucine zipper dimerization domain
- rhBMP-2:
-
recombinant human BMP-2
- s-tag:
-
15-a.a. fragment of bovine pancreatic ribonuclease A
References
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. (1988) Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528–1534.
Israel, D. I., Nove, J., Kerns, K. M., Moutsatsos, I. K., and Kaufman, R. J. (1992) Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells, Growth Factors, 7, 139–150.
Von Einem, S., Erler, S., Bigl, K., Frerich, B., and Schwarz, E. (2011) The proform of BMP-2 exhibits a delayed and reduced activity when compared to mature BMP-2, Growth Factors, 29, 63–71.
Scheufler, C., Sebald, W., and Hulsmeyer, M. (1999) Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution, J. Mol. Biol., 287, 103–115.
Zaitsev, V. V., Karyagina, A. S., and Lunin, V. G. (2009) Bone morphogenetic proteins (BMP): characteristics, prospects of clinical application in traumatology and orthopedics, Vestn. Travmatol. Ortoped. im. N. N. Priorova, 4, 79–84.
Allendorph, G. P., Vale, W. W., and Choe, S. (2006) Structure of the ternary signaling complex of a TGF-β superfamily member, Proc. Natl. Acad. Sci. USA, 103, 7643–7648.
Li, R. H., and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins, Trends Biotechnol., 19, 255–265.
Kirker-Head, C. A. (2000) Potential applications and delivery strategies for bone morphogenetic proteins, Adv. Drug Deliv. Rev., 43, 65–92.
Wang, E. A., Rosen, V., D’Alessandro, J. S., Bauduy, M., Cordes, P., Harada, T., Israel, D. I., Hewick, R. M., Kerns, K. M., and LaPan, P. (1990) Recombinant human bone morphogenetic protein induces bone formation, Proc. Natl. Acad. Sci. USA, 87, 2220–2224.
Ruppert, R., Hoffmann, E., and Sebald, W. (1996) Human bone morphogenetic protein 2 contains a heparinbinding site which modifies its biological activity, Eur. J. Biochem., 237, 295–302.
Vallejo, L. F., Brokelmann, M., Marten, S., Trappe, S., Cabrera-Crespo, J., Hoffmann, A., Gross, G., Weich, H. A., and Rinas, U. (2002) Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in highcelldensity cultures of recombinant Escherichia coli, J. Biotechnol., 94, 185–194.
Vallejo, L. F., and Rinas, U. (2004) Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration, Biotechnol. Bioeng., 85, 601–609.
Boix, T., Gomez-Morales, J., Torrent-Burgues, J., Monfort, A., Puigdomenech, P., and Rodriguez-Clemente, R. (2005) Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite, J. Inorg. Biochem., 99, 1043–1050.
Long, S., Truong, L., Bennett, K., Phillips, A., Wong-Staal, F., and Ma, H. (2006) Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli, Protein Expr. Purif., 46, 374–378.
Zhang, H., Wu, J., Zhang, Y., Fu, N., Wang, J., and Zhao, S. (2010) Optimized procedure for expression and renaturation of recombinant human bone morphogenetic protein-2 at high protein concentrations, Mol. Biol., 37, 3089–3095.
Von Einem, S., Schwarz, E., and Rudolph, R. (2010) A novel twostep renaturation procedure for efficient production of recombinant BMP-2, Protein Expr. Purif., 73, 65–69.
Zhang, Y., Ma, Y., Yang, M., Min, S., Yao, J., and Zhu, L. (2011) Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro, Protein Expr. Purif., 75, 155–160.
Karyagina, A. S., Boksha, I. S., Grunina, T., M., Demidenko, A. V., Poponova, M. S., Sergienko, O. V., Lyashchuk, A. M., Galushkina, Z. M., Soboleva, L. A., Osidak, E. O., Semikhin, A. S., Gromov, A. V., and Lunin, V. G. (2016) Optimization of rhBMP-2 activeform production in a heterologous expression system using microbiological and molecular genetic approaches, Mol. Genet. Microbiol. Virol., 31, 208–213.
Raines, R. T., McCormick, M., Van Oosbree, T. R., and Mierendorf, R. C. (2000) The stag fusion system for protein purification, Methods Enzymol., 326, 362–376.
Deiss, S., Alvarez, B. H., Bar, K., Ewers, C. P., Coles, M., Albrecht, R., and Hartmann, M. D. (2014) Your personalized protein structure: Andrei N. Lupas fused to GCN4 adaptors, J. Struct. Biol., 186, 380–385.
Sambrook, J., Fritch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
Boksha, I. S., Lavrova, N. V., Grishin, A. V., Demidenko, A. V., Lyashchuk, A. M., Galushkina, Z. M., Ovchinnikov, R. S., Umyarov, A. M., Avetisian, L. R., Chernukha, M. Iu., Shaginian, I. A., Lunin, V. G., and Karyagina, A. S. (2016) Staphylococcus simulans recombinant lysostaphin: production, purification, and determination of antistaphylococcal activity, Biochemistry (Moscow), 81, 502–510.
Gasparian, M. E., Ostapchenko, V. G., Schulga, A. A., Dolgikh, D. A., and Kirpichnikov, M. P. (2003) Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli, Protein Expr. Purif., 31, 133–139.
Sharapova, N. E., Kotnova, A. P., Galushkina, Z. M., Lavrova, N. V., Poletaeva, N. N., Tukhvatulin, A. E., Semikhin, A. S., Gromov, A. V., Soboleva, L. A., Ershova, A. S., Zaitsev, V. V., Sergeenko, O. V., Lunin, V. G., and Karyagina, A. S. (2010) Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo, Mol. Biol. (Moscow), 44, 1036–1044.
Chen, B., Lin, H., Wang, J., Zhao, Y., Wang, B., Zhao, W., Sun, W., and Dai, J. (2007) Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagentargeting bone morphogenetic protein-2, Biomaterials, 28, 1027–1035.
Hwang, C. J., Vaccaro, A. R., Lawrence, J. P., Hong, J., Schellekens, H., Alaoui-Ismaili, M. H., and Falb, D. (2009) Immunogenicity of bone morphogenetic proteins, J. Neurosurg. Spine, 10, 443–451.
Bartov, M. S., Gromov, A. V., Poponova, M. S., Savina, D. M., Nikitin, K. E., Grunina, T. M., Manskikh, V. N., Gra, O. A., Lunin, V. G., Karyagina, A. S., and Gintsburg, A. L. (2016) Modern approaches to studies of new osteogenic biomaterials on the model of regeneration of criticalsize cranial defects in rats, Bull. Exp. Biol. Med., 162, 273–276.
Gaifullin, N. M., Karyagina, A. S., Gromov, A. V., Terpilovskiy, A.A., Malanin, D. A., Demeshchenko, M. V., and Novochadov, V. V. (2016) Morphological characteristics of osseointegration of titanium implants with bioactive coating and recombinant bone morphogenic protein, Morfologiya, 149, 77–84.
Chang, P.-C., Lang, N. P., and Giannobile, W. V. (2010) Evaluation of functional dynamics during osseointegration and regeneration associated with oral implants, Oral Implants Res., 21, 1–12.
Andreev, A. Yu., Zakharov, V. D., Zairatyants, O. V., Borzenok, S. A., Khubetsova, M. Kh., Osidak, E. O., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Prospects for the use of bone growth factor as a component of collagen matrix for cornea strengthening (experimental study), Sovr. Tekhnol. Oftalmol., 4, 11–16.
Zakharov, V. D., Andreev, A. Yu., Zairatyants, O. V., Osidak, E. O., Borzenok, S. A., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Morphological changes in rabbit cornea caused by the bone and cartilage growth factor rhBMP-2 used as a component of intracorneal implant, Klin. Eksp. Morfol., 4, 36–42.
Author information
Authors and Affiliations
Corresponding author
Additional information
To whom correspondence should be addressed.
Original Russian Text © A. S. Karyagina, I. S. Boksha, T. M. Grunina, A. V. Demidenko, M. S. Poponova, O. V. Sergienko, A. M. Lyashchuk, Z. M. Galushkina, L. A. Soboleva, E. O. Osidak, M. S. Bartov, A. V. Gromov, V. G. Lunin, 2017, published in Biokhimiya, 2017, Vol. 82, No. 5, pp. 817-831.
Rights and permissions
About this article
Cite this article
Karyagina, A.S., Boksha, I.S., Grunina, T.M. et al. Two variants of recombinant human bone morphogenetic protein-2 (rhBMP-2) with additional protein domains: Synthesis in an Escherichia coli heterologous expression system. Biochemistry Moscow 82, 613–624 (2017). https://doi.org/10.1134/S0006297917050091
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917050091